✦ LIBER ✦

An Analysis of Safety Data from Five Phase III Clinical Trials on the Use of Botulinum Neurotoxin Type A-ABO for the Treatment of Glabellar Lines

✍ Scribed by Mark Rubin; Jeffrey Dover; Corey Maas; Mark Nestor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

An Analysis of Efficacy Data from Four P

✍ Leslie Baumann; Fredric S. Brandt; Michael A.C. Kane; Lisa M. Donofrio 📂 Article 📅 2009 🏛 Sage Publications 🌐 English ⚖ 232 KB

An Analysis of the Long-Term Safety Data

✍ Joel L. Cohen; Joel Schlessinger; Sue Ellen Cox; Xiaoming Lin 📂 Article 📅 2009 🏛 Sage Publications 🌐 English ⚖ 385 KB

An analysis of efficacy data from five p

📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Long-term safety of repeated administrat

✍ Gary D. Monheit; Joel L. Cohen 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 187 KB

Safety results from a pooled analysis of

✍ Langley, R.G.; Papp, K.; Gottlieb, A.B.; Krueger, G.G.; Gordon, K. B.; Williams, 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 232 KB